Browsing Tag
US FDA
379 posts
Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US
Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…
October 13, 2019
Lilly bags Reyvow FDA approval for acute treatment of migraine
Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug…
October 13, 2019
Verastem gets FDA orphan drug status for COPIKTRA for T-Cell lymphoma
Verastem Oncology has secured orphan drug designation for COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K), from…
October 7, 2019
Stokes’ STK-001 secures FDA orphan drug designation for Dravet Syndrome
US biotech company Stoke Therapeutics has secured orphan drug designation for its lead product candidate – STK-001 from…
August 7, 2019
Celgene bags Otezla FDA approval for oral ulcers in Behcet’s Disease
Otezla FDA approval : US biotech company Celgene has bagged approval from the US Food and Drug Administration…
July 21, 2019
Sensorion gets FDA nod for SENS-401 trial for inner ear condition
French inner ear diseases company Sensorion has secured the investigational new drug (IND) clearance from the US Food…
July 13, 2019
Grifols bags Xembify FDA approval for primary immunodeficiencies
Xembify FDA approval : Spanish pharma company Grifols has been granted approval from the US Food and Drug…
July 7, 2019
ZULRESSO postpartum depression drug set to be launched in US by Sage Therapeutics
CNS biopharma company Sage Therapeutics is all set to commercially launch its ZULRESSO (brexanolone) injection in the US…
June 15, 2019
Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC
Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA)…
May 5, 2019
Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men
New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer…
April 17, 2019